Financial Personal
Avicanna Announces United States Patent and Trademark Office Issuance of Patent on Topical Technology
USPTO issues Patent No. US 20230025693A1 (“Patent”) that covers Avicanna’s deep penetrating topicalcannabinoid composition and methods for treating musculoskeletal inflammation and pain TORONTO, Aug. 27, 2024 (GLOBE NEWSWIRE) — Avicanna Inc. (“
Although various drugs are currently available to alleviate pain, they are associated with various debilitating side effects. Topical formulations can potentially provide pain relief, in particular improved formulations for the delivery of active ingredients directly into the deep layers of tissue to provide better efficacy and reduced gastro-intestinal, central nervous system and cardiovascular side effects. Read More
